Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | -27.71%74.79K | 491.37%103.46K | ||||||||
| Gross profit | 27.71%-74.79K | -491.37%-103.46K | ||||||||
| Operating expense | -43.74%149.16K | -56.87%733.76K | -57.46%56.07K | -59.85%191.95K | -65.22%220.63K | -42.01%265.12K | -59.02%1.7M | -86.09%131.8K | -79.69%478.11K | 20.54%634.36K |
| Selling and administrative expenses | -34.84%130.92K | -50.39%664.26K | -32.36%134.43K | -52.92%160.49K | -65.23%168.42K | -36.18%200.92K | -64.07%1.34M | -61.92%198.74K | -85.52%340.89K | -7.96%484.38K |
| -Selling and marketing expense | --0 | -97.14%14.7K | --0 | --0 | -96.45%7.35K | -94.24%7.35K | -51.53%514.14K | 212.53%39.02K | -70.37%140.44K | -47.58%207.19K |
| -General and administrative expense | -32.37%130.92K | -21.24%649.56K | -15.84%134.43K | -19.94%160.49K | -41.89%161.07K | 3.33%193.57K | -69.06%824.7K | -71.30%159.72K | -89.34%200.46K | 111.65%277.19K |
| Research and development costs | ---- | -95.74%9.18K | ---- | ---- | ---- | ---- | 145.10%215.17K | ---- | ---- | ---- |
| Depreciation amortization depletion | -52.26%10.7K | ---- | ---- | -47.44%19.28K | 51.05%22.41K | 85.15%22.41K | ---- | ---- | --36.69K | --14.83K |
| -Depreciation and amortization | -52.26%10.7K | ---- | ---- | -47.44%19.28K | 51.05%22.41K | 85.15%22.41K | ---- | ---- | --36.69K | --14.83K |
| Provision for doubtful accounts | ---- | --23.31K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other operating expenses | -81.94%7.55K | -74.90%37.01K | 78.60%-46.76K | -87.89%12.17K | -77.95%29.81K | -67.92%41.79K | -56.36%147.44K | ---218.49K | --100.53K | --135.15K |
| Operating profit | 43.74%-149.16K | 55.20%-808.55K | 44.38%-130.86K | 59.85%-191.95K | 65.22%-220.63K | 42.01%-265.12K | 56.71%-1.8M | 75.62%-235.26K | 79.69%-478.11K | -20.54%-634.36K |
| Net non-operating interest income (expenses) | 20.93%-5.64K | -123.98%-24.11K | -209.44%-6.54K | -136.13%-3.82K | -128.20%-6.63K | -111.78%-7.13K | 64.96%100.54K | -88.66%5.98K | 103.27%10.56K | 1,388.54%23.5K |
| Non-operating interest income | 95.59%444 | -97.35%3.47K | -81.14%2.57K | -98.68%243 | -98.87%431 | -99.62%227 | 111.30%130.74K | -74.36%13.61K | 242.67%18.46K | 2,075.84%38.19K |
| Non-operating interest expense | -17.34%6.08K | -8.68%27.58K | 19.37%9.11K | -48.56%4.06K | -51.92%7.06K | --7.35K | 3,158.14%30.2K | 2,055.08%7.63K | 4,075.66%7.89K | 8,242.05%14.68K |
| Other net income (expenses) | -92.42%2.57K | -15,392.75%-53.45K | 94.03%-41.22K | -161.22%-61.45K | -97.17%15.34K | -29.71%33.88K | -100.06%-345 | -183.80%-690.64K | 145.78%100.37K | 3,056.97%541.72K |
| Gain on sale of security | 297.69%2.57K | 94.67%-478 | 80.53%-580 | 131.68%409 | 14.27%993 | 76.66%-1.3K | -147.75%-8.97K | -122.15%-2.98K | -106.88%-1.29K | 104.64%869 |
| Special income (charges) | --0 | 86.19%-82.97K | 93.52%-45.01K | -166.39%-62.52K | --0 | --24.56K | -137.05%-600.99K | ---695.16K | 137.14%94.17K | --0 |
| -Less:Impairment of capital assets | ---- | --0 | ---- | ---- | ---- | ---- | 132.99%590.71K | ---- | ---- | ---- |
| -Less:Write off | ---- | ---- | ---- | 52.20%-45.01K | ---- | ---- | ---- | ---- | ---94.17K | ---- |
| -Gain on sale of property,plant,equipment | --0 | -706.41%-82.97K | --0 | ---107.53K | --0 | --24.56K | ---10.29K | ---10.29K | --0 | --0 |
| Other non-operating income (expenses) | ---- | -95.08%30K | -41.63%4.38K | -91.29%653 | -97.35%14.35K | -80.24%10.62K | -27.55%609.62K | -99.09%7.5K | -51.73%7.5K | 129,599.76%540.85K |
| Income before tax | 36.14%-152.23K | 48.02%-886.11K | 80.58%-178.61K | 29.95%-257.22K | -206.52%-211.92K | 31.60%-238.37K | 51.63%-1.7M | -943.44%-919.92K | 85.70%-367.17K | 87.27%-69.14K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 36.14%-152.23K | 48.02%-886.11K | 80.58%-178.61K | 29.95%-257.22K | -206.52%-211.92K | 31.60%-238.37K | 51.63%-1.7M | -943.44%-919.92K | 85.70%-367.17K | 87.27%-69.14K |
| Net income continuous operations | 36.14%-152.23K | 48.02%-886.11K | 80.58%-178.61K | 29.95%-257.22K | -206.52%-211.92K | 31.60%-238.37K | 51.63%-1.7M | -943.44%-919.92K | 85.70%-367.17K | 87.27%-69.14K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 36.14%-152.23K | 48.02%-886.11K | 80.58%-178.61K | 29.95%-257.22K | -206.52%-211.92K | 31.60%-238.37K | 51.63%-1.7M | -943.44%-919.92K | 85.70%-367.17K | 87.27%-69.14K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 36.14%-152.23K | 48.02%-886.11K | 80.58%-178.61K | 29.95%-257.22K | -206.52%-211.92K | 31.60%-238.37K | 51.63%-1.7M | -943.44%-919.92K | 85.70%-367.17K | 87.27%-69.14K |
| Diluted earnings per share | 0 | 66.67%-0.03 | 0 | 66.10%-0.0102 | -183.55%-0.0101 | 0 | 57.14%-0.09 | -300.00%-0.06 | 80.00%-0.03 | 88.17%-0.0036 |
| Basic earnings per share | 0 | 66.67%-0.03 | 0 | 66.10%-0.0102 | -183.55%-0.0101 | 0 | 57.14%-0.09 | -300.00%-0.06 | 80.00%-0.03 | 88.17%-0.0036 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.